Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
Ramantamig (JNJ-79635322) 是一种新型的 T 细胞结合三特异性抗体,靶向 BCMA、GPRC5D 和 CD3,用于多发性骨髓瘤模型研究。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025030027
Pillarisetti, Kodandaram; Yang, Danlin; Luistro, Leopoldo; Yao, Jianhong; Smith, Melissa; Vulfson, Peter; Testa, James S; Ponticiello, Randolph; Brodeur, Scott; Heidrich, Bradley; Packman, Kathryn; Singh, Sanjaya; Attar, Ricardo; Elsayed, Yusri; Philippar, Ulrike